Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Atrophic Vaginitis × Dehydroepiandrosterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Sexual Dysfunction, Physiological 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Depression 1 Carcinoma, Ovarian Epithelial 1 Atrophic Vaginitis 1 Anxiety Disorders 1

Interventions

Dehydroepiandrosterone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03740945 2020-07-31

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

EndoCeutics Inc.

Phase 3 Withdrawn

Breast Neoplasms, Atrophic Vaginitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡